Algo version: 0.98b
SYRS is listed at the NASDAQ Exchange
SYRS [SYRS]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is SYRS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Syros Pharmaceuticals Inc 10 years ago, but if you had invested on Thursday 30th of June 2016 when the price was $181.50, you would have made a loss of $-181.21 per share or -99.84%

Yes, the average daily trading liquidity for Syros Pharmaceuticals Inc is $2.37 million. You should therefore be able to get in and out of your positions relatively fast.

Syros Pharmaceuticals Inc has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Syros Pharmaceuticals Inc to be high [1 out of 1]